We note that sequencing studies report that clusterin is typically lower in expression in colorectal cancer than normal tissue (73), and the observation of longer OS of patients with the CRLM-CA phenotype suggests clusterin can also provide a cytoprotective role. This evidence concerns the gene CLU and colorectal cancer.